Acadia Pharmaceuticals target price cut to $36 from $37
ACAD•RBC cut its target price for Acadia Pharmaceuticals to $36 from $37.
Related News
Ermenegildo Zegna to report Q3 2026 unaudited revenues
ZGN•
Lamb Weston Holdings: Barclays raises target price to $58 from $56
LW•
Huize to present at LD Micro Main Event in Los Angeles
HUIZ•
IonQ advances to final stage of US quantum testing program
IONQ•
German government raises growth forecasts for 2026 and 2027
EWG•